ICNC2018 Abstracts & Symposia Proposals, ICNC 2014

Font Size: 
THE EVALUATION OF PROPHYLACTİC TREATMENT OF THE CHİLDREN WITH MIGRAINE BY USING PEDMIDAS SCORE
yasemin topcu

Last modified: 2014-04-03

Abstract


OBJECTIVES: Migraine is a significant problem and childhood migraine can significantly impair a child’s quality of life. The aim of this study is to evaluate the efficacy of prophylactic treatments of our patients diagnosed as migraine by using Pediatric Migraine Disability Assessment score(PedMIDAS).

METHODS: Children with migraine aged between 6-17 years were followed-up at least 6 months and PedMIDAS questionnaire were applied at 0, 3 and 6th months.

RESULTS: The changes between PedMIDAS scores of 0-3 month, 0-6 month ve 3-6 month of patients who were given prophylactic therapy were significantly higher than the patients who did not receive any therapy. The changes between PedMIDAS scores of 0-3 months were 21.11±14.68 days in topiramate group, 9.00±9.30 days in flunarizine group and 26.80±11.89 days in propranolol group. The changes between PedMIDAS scores of 0-3 months were significantly higher in topiramat and propranolol groups than flunarizine group(p<0.05). The number of days on analgesics treatment significantly decreased in the patients who had topiramate and propranolol treatments(p<0.05), whereas remained unchanged in flunarizine prophylaxis group(p>0.05).

CONCLUSİONS: PedMIDAS scoring system was observed to be useful when evaluating the efficacy of pharmacological agents used in the prophylactic therapy of pediatric migraine. Topiramat and propronalol therapies were shown to lower the PedMIDAS scores better than flurinazine therapy.


Keywords


Pediatric migraine; PedMIDAS; prophylactic therapy

References


  1. Hershey AD, Powers SW, Vockell ALB, Lecates SL, Kabbouche MA, Maynard MK.  PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology 2001;57:2034-2039
  2. Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine--an open-label study. Headache 2007;47:427-430
  3. Hirfanoğlu T, Serdaroğlu A, Gulbahar O, Cansu A. Prophylactic drugs and cytokine and leptin levels in children with migraine. Pediatr Neurol 2009;41:281-287
  4. Lewis D, Paradiso E. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Headache 2007;47:1409-1417
  5. Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47:73-80
  6. Swaiman KF, Ashwal S. Eds. Headaches in infants and children. Pediatric Neurology, 5th ed, Elsevier Saunders; 2012:880-899
  7. Wöber-Bingöl C, Wöber C, Karwautz A. Clinical features of migraine: a cross -sectional study in patients aged three to sixty-nine. Cephalalgia 2004;24:12-17
  8. Fuh JL, Wang SJ, Lu SR, Liao YC, Chen SP, Yang CY. Headache disability among adolescents: A student population-based study. Headache 2010;50:210-218
  9. Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother 2007;41:1181-1190
  10. Lewis DW. Pediatric migraine. Pediatr Rev 2007;28:43-53
  11. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004;44:230-237
  12. Levinstein B. A comparative study of cyproheptadine, amitriptyline and propranolol in the treatment of adolescent migraine. Cephalalgia 1991;11:122-123
  13. Hershey AD, Powers SW, Bentti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539-549
  14. Rao BS, Das DG, Taraknath VR, Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India 2000;48:223-226
  15. Lütschg J, Vassella F. The treatment of juvenile migraine using flunarizine or propranolol. Schweiz Med Wochenschr 1990;120:1731- 1736
  16. Pothmann R. Prevention of migraine with flunarizine and acetylsalicylic acid: a double-blind study [In German]. Monatsschr Kinderheilkd 1987;135:646-649
  17. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987;79:593-597
  18. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine: a double-blind study.  Cephalalgia 1985;5:145-148
  19. Unalp A, Uran N, Ozturk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. Child Neurol 2008;23:1377-1381
  20. Verspeelt J, De Locht P, Amery WK. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. Cephalalgia 1996;16:328-336
  21. Luo N, Di W, Zhang A, et al. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Pain Med 2012;13:80-86

 


Conference registration is required in order to view papers.